Follow
Fithria Dyah Ayu Suryanegara
Title
Cited by
Cited by
Year
Public knowledge of self-medication in Ngaglik subdistrict of Sleman regency
D Medisa, FDA Suryanegara, DA Natalia, PF Handayani, DPI Kusuma, ...
JKKI: Jurnal Kedokteran dan Kesehatan Indonesia, 250-256, 2020
162020
The description of Larva free index as COMBI (Communication for behavioral impact) dengue hemorrhagic fever prevention indicator
FDA Suryanegara, S Suparmi, N Setyaningrum
Jurnal Kesehatan Masyarakat 13 (3), 338-344, 2018
82018
Clinical pharmacy services for tuberculosis management: a systematic review
D Iskandar, FDA Suryanegara, JFM Van Boven, MJ Postma
Frontiers in Pharmacology 14, 1186905, 2023
42023
Health-related quality of life in Her2-positive early breast cancer woman using trastuzumab: A systematic review and meta-analysis
SM Khoirunnisa, FDA Suryanegara, D Setiawan, MJ Postma
Frontiers in Pharmacology 14, 1090326, 2023
32023
Facing problems in radiotherapy for breast cancer patients in Yogyakarta, Indonesia: A cohort retrospective study
FDA Suryanegara, MR Rokhman, E Ekaputra, LA de Jong, D Setiawan, ...
Cancer medicine 12 (7), 8851-8859, 2023
22023
Analisis Kinerja Instalasi Farmasirumah Sakit X Purwokertoditinjau Dari Perspektif Customer Balanced Scorecard “Keterjaringan Pasien”
FDA Suryanegara, S Satibi, A Fudholi
Jurnal Ilmiah Farmasi 10 (1), 28-32, 2013
22013
Kinerja Instalasi Farmasi Rumah Sakit X Purwokerto Ditinjau Dari Perspektif Proses Bisnis Internal Balanced Scorecard “Average Dispensary TIME Dan Waktu Pemberian Informasi Obat
FD Ayu, S Satibi, A Fudholi
Jurnal Ilmiah Farmasi 10 (2), 45-50, 2013
12013
A Systematic Review of Health-Related Quality of Life in Women with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab
SM Khoirunnisa, FDA Suryanegara, LA de Jong, D Setiawan, MJ Postma
PharmacoEconomics-open, 1-14, 2024
2024
EE365 Discrepancies Between Actual Costs and Reimbursement Tariffs for Breast Cancer Radiotherapy in Indonesia: A Hospital-Based Retrospective Study
FDA Suryanegara, D Iskandar, E Ekaputra, E Kuntjoro, D Setiawan, ...
Value in Health 26 (12), S121, 2023
2023
EE226 Economic Evaluation of Trastuzumab in HER2-Positive Early Breast Cancer in Indonesia: A Cost-Effectiveness Analysis
S Khoirunnisa, FDA Suryanegara, D Setiawan, MJ Postma, L de Jong
Value in Health 26 (12), S94, 2023
2023
PCR268 The Impact of Radiotherapy Non-Compliance on the Recurrence and Mortality of Breast Cancer Patients: A Systematic Review
FDA Suryanegara, AV Icanervilia, GK Dewi, D Setiawan, L de Jong, ...
Value in Health 25 (12), S442, 2022
2022
Cost consequences analysis of hypertensive outpatients: a study in a private hospital in Yogyakarta special province
DB Pratidina, FDA Suryanegara, DA Nugraheni
Jurnal Ilmiah Farmasi 17 (2), 116-126, 2021
2021
Jurnal Kedokteran dan Kesehatan Indonesia
D Medisa, FDA Suryanegara, DA Natalia, PF Handayani, D Putri, ...
2020
Buku Ajar Praktik Kerja Profesi Apoteker Bidang Rumah Sakit Masa Pandemi Covid-19
PD apt. Suci Hanifah, MS apt. Fithria Dyah Ayu Suryanegara
2020
People's Knowledge on Dengue Hemorrhagic Fever
FDA Suryanegara, N Setyaningrum, S Suparmi, A Triaji, MR Wibowo, ...
Health Science International Conference (HSIC 2017), 119-122, 2017
2017
TINGKAT KEPUASAN PASIEN TERHADAP PELAYANAN RSUD X YOGYAKARTA 2015
FDA Suryanegara, D Medisa, MA Aziz
Jurnal Ilmiah Farmasi 11 (2), 45-54, 2015
2015
Analisis Kinerja Ifrs X Purwokerto Dari Perspektif Pertumbuhan Dan Pembelajaran Balanced Scorecard
FDA Suryanegara, A Fudholi, S Satibi
JMMR (Jurnal Medicoeticolegal dan Manajemen Rumah Sakit) 1 (1), 2012
2012
Pemetaan strategi di instalasi farmasi RSUD Prof. DR. Margono Soekarjo Purwokerto dengan pendekatan balanced scorecard
FDA SURYANEGARA
Universitas Gadjah Mada, 2009
2009
The Impact of Radiotherapy Non-Compliance on the Recurrence and Mortality of Breast Cancer Patients: A Systematic Review and Meta-analysis
FDA Suryanegara
The system can't perform the operation now. Try again later.
Articles 1–19